Opperman CJ - Search Results

Year	Number of Results
2018	2
2020	7
2021	6
2022	5
2023	6
2024	3

1

Activity of novel β-lactam/β-lactamase inhibitor combinations against serine carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa.

Lee SY, Gill CM, Nicolau DP; ERACE-PA Global Study Group. Lee SY, et al. J Antimicrob Chemother. 2023 Dec 1;78(12):2795-2800. doi: 10.1093/jac/dkad225. J Antimicrob Chemother. 2023. PMID: 37840005 Free PMC article.

2

A citywide, clonal outbreak of Pseudomonas aeruginosa.

Opperman CJ, Moodley C, Lennard K, Smith M, Ncayiyana J, Vulindlu M, Gafoor M, Govender N, Ismail H, Bamford C, McCarthy KM, Nicol MP, Centner CM. Opperman CJ, et al. Int J Infect Dis. 2022 Apr;117:74-86. doi: 10.1016/j.ijid.2022.01.039. Epub 2022 Jan 22. Int J Infect Dis. 2022. PMID: 35077877 Free article.

3

Phages for the treatment of Mycobacterium species.

Opperman CJ, Wojno J, Goosen W, Warren R. Opperman CJ, et al. Prog Mol Biol Transl Sci. 2023;201:41-92. doi: 10.1016/bs.pmbts.2023.03.016. Epub 2023 Jun 23. Prog Mol Biol Transl Sci. 2023. PMID: 37770176

4

Phenotypic and genotypic profile of ceftolozane/tazobactam-non-susceptible, carbapenem-resistant Pseudomonas aeruginosa.

Gill CM, Nicolau DP; ERACE-PA Global Study Group. Gill CM, et al. J Antimicrob Chemother. 2022 Dec 23;78(1):252-256. doi: 10.1093/jac/dkac385. J Antimicrob Chemother. 2022. PMID: 36411249 Free PMC article.

5

Treating bacterial infections with bacteriophages in the 21st century.

Opperman CJ, Wojno JM, Brink AJ. Opperman CJ, et al. S Afr J Infect Dis. 2022 Mar 29;37(1):346. doi: 10.4102/sajid.v37i1.346. eCollection 2022. S Afr J Infect Dis. 2022. PMID: 35399556 Free PMC article.

6

Incorporating direct molecular diagnostics in management algorithms for nontuberculous mycobacteria: Is it high time?

Opperman CJ, Singh S, Goosen W, Cox H, Warren R, Esmail A. Opperman CJ, et al. IJID Reg. 2023 Dec 13;10:140-145. doi: 10.1016/j.ijregi.2023.12.003. eCollection 2024 Mar. IJID Reg. 2023. PMID: 38304760 Free PMC article. Review.

7

Specimen rejection in a high-throughput TB laboratory: A descriptive study.

Zerbini MS, Singh S, Botha M, Ghebrekristos Y, Opperman CJ. Zerbini MS, et al. Among authors: opperman cj. S Afr Med J. 2023 Oct 23;113(10):6-7. doi: 10.7196/SAMJ.2023.v113i10.1364. S Afr Med J. 2023. PMID: 37881905 Free article. No abstract available.

8

In vitro activity of cefiderocol against a global collection of carbapenem-resistant Pseudomonas aeruginosa with a high level of carbapenemase diversity.

Gill CM, Santini D, Nicolau DP; ERACE-PA Global Study Group. Gill CM, et al. J Antimicrob Chemother. 2024 Feb 1;79(2):412-416. doi: 10.1093/jac/dkad396. J Antimicrob Chemother. 2024. PMID: 38153232 Free PMC article.

9

Aspergillus niger otomycosis in a child with chronic otitis externa.

Opperman CJ, Copelyn J. Opperman CJ, et al. S Afr J Infect Dis. 2020 Jun 25;35(1):128. doi: 10.4102/sajid.v35i1.128. eCollection 2020. S Afr J Infect Dis. 2020. PMID: 34485473 Free PMC article.

10

Exogenous fungal endophthalmitis in a potato farm worker.

Booley G, Chanda R, Daries P, Misland C, Brink AJ, Linde L, Opperman CJ. Booley G, et al. Among authors: opperman cj. S Afr J Infect Dis. 2021 Dec 17;36(1):329. doi: 10.4102/sajid.v36i1.329. eCollection 2021. S Afr J Infect Dis. 2021. PMID: 34966818 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

26 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year